Wells Fargo Maintains Overweight on Thermo Fisher Scientific, Lowers Price Target to $615

Benzinga Newsdesk www.benzinga.com Negative 88.3%

Neg 88.3% Neu 0% Pos 0%

Wells Fargo analyst Brandon Couillard maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and lowers the price target from $675 to $615.